US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report
The United States and the United Kingdom are reportedly set to reach an agreement on a zero-tariffs deal on pharmaceuticals.
According to a report by The Times, the deal will result in zero tariffs on pharmaceutical products imported in the U.S. from the U.K. It will also lead to an increase in the U.K. government's spending on the National Health Service (NHS).
The report states that the agreement between the U.S. and the U.K. is expected to be announced in the coming days. The U.K. government is also said to have agreed to a reduction in the industry sales rebate on NHS drug prices.
AstraZeneca Plc.'s (AZN) shares were up 0.1% in Monday's pre-market trade. Retail sentiment around the company trended in the 'bullish' territory at the time of writing. AstraZeneca is the U.K.'s largest pharmaceutical company.
Get updates to this story developing directly on Stocktwits.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment